The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -54.71%.However, over the last six months, we can see a stronger performance of -16.42%. Over the last 30 days, the price of RLAY has fallen by 20.59%. And in the last five days, it has surged by 7.01%.
At present, Relay Therapeutics Inc (RLAY) has a stock price of $3.89. In the previous session, the stock saw a rise, peaking at $29.0 after an opening price of $3.94. The day’s lowest price was $4.0, and it closed at $3.71.
Relay Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $10.72 on 09/09/24 and a low of $1.77 for the same time frame on 04/07/25.
52-week price history of RLAY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Relay Therapeutics Inc’s current trading price is -63.67% away from its 52-week high, while its distance from the 52-week low is 119.44%. The stock’s price range during this period has varied between$1.77 and $10.72. The Relay Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.36 million for the day, a figure considerably higher than their average daily volume of 1.91 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Relay Therapeutics Inc (RLAY) has experienced a quarterly rise of 32.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 667.78M and boasts a workforce of 261 employees.
Relay Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 6 analysts are rating Relay Therapeutics Inc as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.14, with a change in price of +0.60. Similarly, Relay Therapeutics Inc recorded 2,265,520 in trading volume during the last 100 days, posting a change of +18.31%.
RLAY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RLAY stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
RLAY Stock Stochastic Average
As of today, Relay Therapeutics Inc’s raw stochastic average for the last 50 days stands at 98.74%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 98.03%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 82.68% and 72.13%, respectively.
